Literature DB >> 29458695

Comorbid Insomnia With Obstructive Sleep Apnea: Clinical Characteristics and Risk Factors.

Yong Won Cho1, Keun Tae Kim1, Hye-Jin Moon1,2, Valeriy R Korostyshevskiy3, Gholam K Motamedi4, Kwang Ik Yang5.   

Abstract

STUDY
OBJECTIVES: Obstructive sleep apnea (OSA) and chronic insomnia are two common sleep disorders and both are considered independent risk factors for heart disease. The aim of this study was to investigate the prevalence of comorbid insomnia with OSA and to compare its clinical characteristics with those of OSA without insomnia.
METHODS: Patients who visited two tertiary university hospital sleep centers were screened. Those with a diagnosis of OSA using polysomnography were divided into two groups based on their scores on the Korean version of the Insomnia Severity Index (ISI-K): OSA with insomnia (OSA+I) (ISI-K score ≥ 15) and OSA without insomnia (OSA-I) (ISI-K score < 15). Subjective symptoms were evaluated using sleep questionnaires including ISI-K. Demographic and clinical characteristics of OSA+I and OSA-I were compared.
RESULTS: Out of 476 patients with OSA, 139 (29.2%) had significant insomnia. Patients in the OSA+I group had a higher percentage of females (35.3% versus 19.6%, P < .001) and have higher rates of heart disease (19.4% versus 8.6%, P < .001). OSA+I group showed lower quality of life, lower quality of sleep, higher sleep propensity, and higher depression as measured by the Korean versions of the Short-Form 36-Item Health Survey, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Beck Depression Inventory, respectively. There were no significant differences in adherence to continuous positive airway pressure between the groups.
CONCLUSIONS: There is a high prevalence of comorbid insomnia with OSA (29.2%), consistent with previous findings in Western studies. Comorbid insomnia with OSA may constitute a cumulative risk factor for cardiovascular disease. These findings warrant further investigation into the mechanisms involved in its pathogenesis and devising more efficient treatments.
© 2018 American Academy of Sleep Medicine.

Entities:  

Keywords:  comorbid insomnia; heart disease; obstructive sleep apnea

Mesh:

Year:  2018        PMID: 29458695      PMCID: PMC5837842          DOI: 10.5664/jcsm.6988

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  52 in total

1.  Insomnia symptoms influence CPAP compliance.

Authors:  Christoph Pieh; Magdalena Bach; Roland Popp; Cecilia Jara; Tatjana Crönlein; Göran Hajak; Peter Geisler
Journal:  Sleep Breath       Date:  2012-02-04       Impact factor: 2.816

2.  Sleep apnea-plus: prevalence, risk factors, and association with cardiovascular diseases using United States population-level data.

Authors:  Nicholas T Vozoris
Journal:  Sleep Med       Date:  2012-04-03       Impact factor: 3.492

3.  Insomnia in untreated sleep apnea patients compared to controls.

Authors:  Erla Björnsdóttir; Christer Janson; Thorarinn Gíslason; Jón F Sigurdsson; Allan I Pack; Philip Gehrman; Bryndís Benediktsdóttir
Journal:  J Sleep Res       Date:  2011-10-12       Impact factor: 3.981

4.  Prevalence of insomnia symptoms in patients with sleep-disordered breathing.

Authors:  B Krakow; D Melendrez; E Ferreira; J Clark; T D Warner; B Sisley; D Sklar
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

5.  Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Vishesh K Kapur; Dennis H Auckley; Susmita Chowdhuri; David C Kuhlmann; Reena Mehra; Kannan Ramar; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

6.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

7.  Polysomnographic respiratory abnormalities in asymptomatic individuals.

Authors:  Milena K Pavlova; Jeanne F Duffy; Steven A Shea
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

8.  Somatic arousal and sleepiness/fatigue among patients with sleep-disordered breathing.

Authors:  Morris S Gold; Tshering Amdo; Nadia Hasaneen; Avram R Gold
Journal:  Sleep Breath       Date:  2016-01-06       Impact factor: 2.816

9.  Sleep disorders in US military personnel: a high rate of comorbid insomnia and obstructive sleep apnea.

Authors:  Vincent Mysliwiec; Jessica Gill; Hyunhwa Lee; Tristin Baxter; Roslyn Pierce; Taura L Barr; Barry Krakow; Bernard J Roth
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

10.  Co-occurring insomnia and obstructive sleep apnea.

Authors:  Kenneth L Lichstein; S Justin Thomas; Julie A Woosley; James D Geyer
Journal:  Sleep Med       Date:  2013-06-13       Impact factor: 3.492

View more
  21 in total

1.  Randomized controlled trial of an integrated approach to treating insomnia and improving the use of positive airway pressure therapy in veterans with comorbid insomnia disorder and obstructive sleep apnea.

Authors:  Cathy A Alessi; Constance H Fung; Joseph M Dzierzewski; Lavinia Fiorentino; Carl Stepnowsky; Juan C Rodriguez Tapia; Yeonsu Song; Michelle R Zeidler; Karen Josephson; Michael N Mitchell; Stella Jouldjian; Jennifer L Martin
Journal:  Sleep       Date:  2021-04-09       Impact factor: 5.849

2.  Predictors of Insomnia Severity Index Profiles in United States Veterans With Obstructive Sleep Apnea.

Authors:  Douglas M Wallace; William K Wohlgemuth
Journal:  J Clin Sleep Med       Date:  2019-10-30       Impact factor: 4.062

3.  Insomnia symptoms are associated with an increased risk of type 2 diabetes mellitus among adults aged 50 and older.

Authors:  Wenqin Yao; Jia Luo; Xiaohui Yu; Wenjie Jiang; Dongfeng Zhang
Journal:  Sleep Breath       Date:  2021-09-26       Impact factor: 2.655

Review 4.  Sleep Deficiency in Obstructive Sleep Apnea.

Authors:  Olurotimi Adekolu; Andrey Zinchuk
Journal:  Clin Chest Med       Date:  2022-06       Impact factor: 4.967

5.  Orthodontic interventions as a management option for children with residual obstructive sleep apnea: a cohort study protocol.

Authors:  Nathalia Carolina Fernandes Fagundes; Arnaldo Perez-Garcia; Daniel Graf; Carlos Flores-Mir; Giseon Heo
Journal:  BMJ Open       Date:  2022-06-15       Impact factor: 3.006

6.  Association between insomnia and type 2 diabetes mellitus in Han Chinese individuals in Shandong Province, China.

Authors:  Yanhong Zhang; Yuanyuan Lin; Jianwu Zhang; Li Li; Xinxin Liu; Tianhe Wang; Zhenzhong Gao
Journal:  Sleep Breath       Date:  2018-06-30       Impact factor: 2.816

7.  Association of adherence to the Mediterranean diet and physical activity habits with the presence of insomnia in patients with obstructive sleep apnea.

Authors:  Ioanna Kechribari; Meropi D Kontogianni; Michael Georgoulis; Kallirroi Lamprou; Elena Critselis; Emmanouil Vagiakis; Nikos Yiannakouris
Journal:  Sleep Breath       Date:  2021-04-04       Impact factor: 2.816

8.  Depressive Symptoms in Comorbid Obstructive Sleep Apnea and Insomnia: An Integrative Review.

Authors:  Bomin Jeon; Faith S Luyster; Judith A Callan; Eileen R Chasens
Journal:  West J Nurs Res       Date:  2021-02-03       Impact factor: 1.774

9.  Metabolic outcomes in adults with type 2 diabetes and sleep disorders.

Authors:  Christopher C Imes; Zhadyra Bizhanova; Susan M Sereika; Mary T Korytkowski; Charles W Atwood; Lora E Burke; Jacob Kariuki; Jonna L Morris; Robert Stansbury; Patrick J Strollo; Eileen R Chasens
Journal:  Sleep Breath       Date:  2021-06-09       Impact factor: 2.816

10.  Effect of depression, anxiety, and stress symptoms on response to cognitive behavioral therapy for insomnia in patients with comorbid insomnia and sleep apnea: a randomized controlled trial.

Authors:  Alexander Sweetman; Leon Lack; R Doug McEvoy; Peter G Catcheside; Nick A Antic; Ching Li Chai-Coetzer; James Douglas; Amanda O'Grady; Nicola Dunn; Jan Robinson; Denzil Paul; Simon Smith
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.